Contaminated heart medication leads to Health Canada recall
Health Canada is recalling 28 commonly used heart medications due to contamination with a potential carcinogen. The recall affects medications containing valsartan.
The drugs are used to treat high blood pressure and prevent heart attacks and strokes.
The drugs are manufactured by five companies whose valsartan was supplied by China-based Zhejiang Huahai Pharmaceuticals.
Health Canada said it is monitoring the product recalls, and advises anyone using an affected product to contact their health-care practitioner as soon as possible to discuss treatment options.
Here is the link to Health Canada's site listing all recalled products: